エーザイの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/04/07 | 7,553 | 7,604 | 7,474 | 7,529 | +20 | +0.3% | 1,190,100 |
2023/04/06 | 7,399 | 7,520 | 7,387 | 7,509 | +150 | +2% | 1,189,300 |
2023/04/05 | 7,494 | 7,501 | 7,346 | 7,359 | -135 | -1.8% | 923,000 |
2023/04/04 | 7,495 | 7,501 | 7,394 | 7,494 | +64 | +0.9% | 916,500 |
2023/04/03 | 7,482 | 7,494 | 7,395 | 7,430 | -74 | -1% | 974,700 |
2023/03/31 | 7,470 | 7,560 | 7,419 | 7,504 | +94 | +1.3% | 1,524,900 |
2023/03/30 | 7,396 | 7,445 | 7,352 | 7,410 | -44 | -0.6% | 1,234,900 |
2023/03/29 | 7,302 | 7,469 | 7,268 | 7,454 | +152 | +2.1% | 1,285,600 |
2023/03/28 | 7,366 | 7,383 | 7,262 | 7,302 | -1 | ±0% | 668,200 |
2023/03/27 | 7,280 | 7,316 | 7,209 | 7,303 | +136 | +1.9% | 837,900 |
2023/03/24 | 7,180 | 7,198 | 7,067 | 7,167 | -22 | -0.3% | 1,025,100 |
2023/03/23 | 7,222 | 7,230 | 7,077 | 7,189 | -126 | -1.7% | 1,589,900 |
2023/03/22 | 7,328 | 7,368 | 7,266 | 7,315 | +87 | +1.2% | 945,800 |
2023/03/20 | 7,450 | 7,489 | 7,228 | 7,228 | -284 | -3.8% | 1,106,300 |
2023/03/17 | 7,467 | 7,512 | 7,411 | 7,512 | +137 | +1.9% | 1,096,700 |
2023/03/16 | 7,325 | 7,392 | 7,232 | 7,375 | -91 | -1.2% | 1,283,200 |
2023/03/15 | 7,512 | 7,565 | 7,421 | 7,466 | +19 | +0.3% | 1,365,500 |
2023/03/14 | 7,256 | 7,578 | 7,206 | 7,447 | +155 | +2.1% | 2,310,300 |
2023/03/13 | 7,290 | 7,302 | 7,224 | 7,292 | -76 | -1% | 1,003,000 |
2023/03/10 | 7,375 | 7,460 | 7,364 | 7,368 | -77 | -1% | 1,577,900 |
2023/03/09 | 7,450 | 7,479 | 7,382 | 7,445 | -33 | -0.4% | 1,028,800 |
2023/03/08 | 7,402 | 7,493 | 7,377 | 7,478 | +59 | +0.8% | 838,500 |
2023/03/07 | 7,459 | 7,520 | 7,402 | 7,419 | -6 | -0.1% | 1,242,900 |
2023/03/06 | 7,604 | 7,630 | 7,425 | 7,425 | -137 | -1.8% | 1,527,700 |
2023/03/03 | 7,478 | 7,612 | 7,443 | 7,562 | +90 | +1.2% | 1,492,100 |
2023/03/02 | 7,336 | 7,499 | 7,333 | 7,472 | +149 | +2% | 1,194,600 |
2023/03/01 | 7,301 | 7,355 | 7,281 | 7,323 | -29 | -0.4% | 976,900 |
2023/02/28 | 7,389 | 7,460 | 7,333 | 7,352 | -85 | -1.1% | 1,383,800 |
2023/02/27 | 7,467 | 7,494 | 7,432 | 7,437 | -97 | -1.3% | 664,000 |
2023/02/24 | 7,559 | 7,560 | 7,403 | 7,534 | -51 | -0.7% | 1,031,000 |
2023/02/22 | 7,675 | 7,677 | 7,511 | 7,585 | -134 | -1.7% | 1,187,400 |
2023/02/21 | 7,772 | 7,810 | 7,681 | 7,719 | -92 | -1.2% | 1,120,000 |
2023/02/20 | 7,684 | 7,825 | 7,650 | 7,811 | +186 | +2.4% | 1,659,700 |
2023/02/17 | 7,532 | 7,682 | 7,485 | 7,625 | +57 | +0.8% | 1,456,400 |
2023/02/16 | 7,480 | 7,632 | 7,480 | 7,568 | +91 | +1.2% | 1,340,900 |
2023/02/15 | 7,474 | 7,494 | 7,411 | 7,477 | -26 | -0.3% | 1,053,200 |
2023/02/14 | 7,550 | 7,607 | 7,489 | 7,503 | +48 | +0.6% | 1,316,900 |
2023/02/13 | 7,470 | 7,530 | 7,432 | 7,455 | -35 | -0.5% | 1,182,400 |
2023/02/10 | 7,645 | 7,649 | 7,485 | 7,490 | -79 | -1% | 2,072,800 |
2023/02/09 | 7,656 | 7,661 | 7,520 | 7,569 | -136 | -1.8% | 1,730,500 |
2023/02/08 | 7,607 | 7,820 | 7,580 | 7,705 | +108 | +1.4% | 2,408,900 |
2023/02/07 | 7,648 | 7,730 | 7,512 | 7,597 | -34 | -0.4% | 2,934,600 |
2023/02/06 | 7,884 | 7,910 | 7,615 | 7,631 | -238 | -3% | 3,208,300 |
2023/02/03 | 7,935 | 8,005 | 7,850 | 7,869 | -66 | -0.8% | 1,282,300 |
2023/02/02 | 8,019 | 8,028 | 7,862 | 7,935 | -84 | -1% | 1,495,500 |
2023/02/01 | 8,021 | 8,047 | 7,987 | 8,019 | +7 | +0.1% | 1,097,600 |
2023/01/31 | 8,100 | 8,113 | 8,000 | 8,012 | -97 | -1.2% | 1,312,000 |
2023/01/30 | 8,130 | 8,213 | 8,081 | 8,109 | -40 | -0.5% | 1,226,700 |
2023/01/27 | 8,288 | 8,288 | 8,131 | 8,149 | -132 | -1.6% | 1,210,100 |
2023/01/26 | 8,355 | 8,385 | 8,264 | 8,281 | -35 | -0.4% | 938,400 |
401~
450
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「エーザイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
エーザイ | 465,000円 | +1.7% | -2.9% | 3.44% | 30.51倍 | 1.60倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
アステラス薬 | 156,200円 | +12.2% | +180.3% | 4.74% | 55.93倍 | 1.83倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 209,400円 | +5.7% | +3.9% | 2.74% | 10.42倍 | 1.38倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
協和キリン | 252,300円 | +11.3% | -5.4% | 2.30% | 19.42倍 | 1.53倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
小野薬 | 174,700円 | -3.5% | -50.2% | 4.58% | 14.15倍 | 1.05倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム